|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.825 USD | +2.73% |
|
+5.34% | -35.32% |
| 01/07 | Aurinia Pharmaceuticals Inc.(NasdaqGM:AUPH) added to Russell Small Cap Comp Value Index | CI |
| 01/07 | Aurinia Pharmaceuticals Inc.(NasdaqGM:AUPH) added to Russell 2500 Value Index | CI |
Aurinia Pharmaceuticals Inc. reiterated revenue guidance for 2023. For the period, company reiterates net product revenue guidance in the range of $120-$140 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.32% | 81Cr | |
| +20.33% | 13TCr | |
| +24.36% | 12TCr | |
| +25.44% | 2.77TCr | |
| -18.45% | 2.03TCr | |
| -15.17% | 1.68TCr | |
| -16.67% | 1.56TCr | |
| +13.03% | 1.48TCr | |
| -47.10% | 1.46TCr | |
| +57.08% | 1.44TCr |
AURINIA PHARMACEUTICALS INC. 
